|1.||Hovinga, Collin A: 1 article (01/2004)|
|2.||White, H S: 1 article (07/2001)|
|3.||Woodhead, J H: 1 article (07/2001)|
|4.||Isoherranen, N: 1 article (07/2001)|
|5.||Bialer, M: 1 article (07/2001)|
01/01/2004 - "Valrocemide is an anticonvulsant agent under development by Teva and Acorda as a potential therapeutic for the treatment of epilepsy. "
01/01/2004 - "In October 2003, a phase II trial using valrocemide as an adjunct therapy in refractory epilepsy patients had been completed and phase III trials were being planned. "
07/01/2001 - "We sought to investigate the anticonvulsant activity of the new antiepileptic drug (AED), valrocemide or TV1901 (VGD) in various animal (rodent) models of human epilepsy to determine its anticonvulsant profile and safety margin. "
|2.||Neuralgia (Stump Neuralgia)
|3.||Bipolar Disorder (Mania)